Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Beginning Cash Balance (2011 - 2020)

INVO Fertility (IVF) reported Beginning Cash Balance of $40000.0 for Q2 2020, up 14.29% on a QoQ basis from $35000.0 in Q3 2019.

INVO Fertility (IVF) has 5 years of Beginning Cash Balance data on file, last reported at $40000.0 in Q2 2020.

  • Quarterly Beginning Cash Balance changed N/A year-over-year to $40000.0 in Q2 2020, while the trailing twelve-month figure through Dec 2020 was $40000.0 (down 59.08% YoY) and the FY2020 annual result came in at $40000.0, down 59.08% from the prior year.
  • Beginning Cash Balance improved to $40000.0 in Q2 2020 per IVF's latest filing, from $35000.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $62743.0 in Q1 2019 and bottomed at $28000.0 in Q2 2018.
  • The 3-year median for Beginning Cash Balance is $37500.0 (2019), against an average of $42833.3.
  • Peak annual rise in Beginning Cash Balance reached 42.86% in 2019, while the deepest fall reached 42.86% in 2019.
  • Tracing IVF's Beginning Cash Balance over 3 years: stood at $30000.0 in 2018, then climbed by 16.67% to $35000.0 in 2019, then advanced by 14.29% to $40000.0 in 2020.
  • Per Business Quant, the three latest IVF Beginning Cash Balance figures stand at $40000.0 (Q2 2020), $35000.0 (Q3 2019), and $62743.0 (Q1 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 40,000.00
Jun 30, 2020 40,000.00
Sep 30, 2019 35,000.00
Sep 30, 2019 35,000.00
Mar 31, 2019 62,743.00
Mar 31, 2019 62,743.00
Dec 31, 2018 30,000.00
Dec 31, 2018 30,000.00
Sep 30, 2018 61,257.00
Sep 30, 2018 61,257.00
Jun 30, 2018 28,000.00
Jun 30, 2018 28,000.00
Dec 31, 2015 20,000.00
Dec 31, 2015 20,000.00
Dec 31, 2011 18,518.00
Dec 31, 2011 18,518.00
Sep 30, 2011 25,000.00
Sep 30, 2011 25,000.00